1BD Stock Overview
A biotechnology company, researches, develops, manufactures, and supplies agarose-based separation products to purify proteins, peptides, and other biomolecules primarily in Sweden.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Bio-Works Technologies AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 0.13 |
| 52 Week High | SEK 1.15 |
| 52 Week Low | SEK 0.082 |
| Beta | 1.21 |
| 11 Month Change | 14.66% |
| 3 Month Change | -55.81% |
| 1 Year Change | -86.70% |
| 33 Year Change | -91.19% |
| 5 Year Change | n/a |
| Change since IPO | -85.43% |
Recent News & Updates
Recent updates
Shareholder Returns
| 1BD | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 10.8% | 3.7% | 0.09% |
| 1Y | -86.7% | 4.1% | 3.1% |
Return vs Industry: 1BD underperformed the German Medical Equipment industry which returned 2.2% over the past year.
Return vs Market: 1BD underperformed the German Market which returned 3% over the past year.
Price Volatility
| 1BD volatility | |
|---|---|
| 1BD Average Weekly Movement | 40.3% |
| Medical Equipment Industry Average Movement | 4.5% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.7% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: 1BD's share price has been volatile over the past 3 months.
Volatility Over Time: 1BD's weekly volatility has increased from 23% to 40% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 36 | Lone Carlbom | www.bio-works.com |
Bio-Works Technologies AB (publ), a biotechnology company, researches, develops, manufactures, and supplies agarose-based separation products to purify proteins, peptides, and other biomolecules primarily in Sweden. It offers activated and affinity resins; GoBio Mini columns; immobilized metal-ion affinity chromatography resins; ion exchange resins; RoboColumns and Optimo PRO 96 well screens; screening kits; and size exclusion chromatography resins. The company’s products are used in antibodies, his-tagged proteins, proteins, peptides, oligonucleotides, and viruses and vaccines applications.
Bio-Works Technologies AB (publ) Fundamentals Summary
| 1BD fundamental statistics | |
|---|---|
| Market cap | €8.09m |
| Earnings (TTM) | -€5.00m |
| Revenue (TTM) | €3.86m |
2.1x
P/S Ratio-1.6x
P/E RatioIs 1BD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 1BD income statement (TTM) | |
|---|---|
| Revenue | SEK 43.90m |
| Cost of Revenue | SEK 17.08m |
| Gross Profit | SEK 26.82m |
| Other Expenses | SEK 83.64m |
| Earnings | -SEK 56.82m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Aug 23, 2024
| Earnings per share (EPS) | -1.46 |
| Gross Margin | 61.10% |
| Net Profit Margin | -129.44% |
| Debt/Equity Ratio | 0% |
How did 1BD perform over the long term?
See historical performance and comparison